THU-116 - The ALBI grade refines prognostic prediction in advanced hepatocellular cancer and enables risk stratification for bleeding events following atezolizumab plus bevacizumab
Resource Type
Abstract
Authors
D’Alessio, Antonio ; Fulgenzi, Claudia ; Scheiner, Bernhard ; Korolewicz, James ; Cheon, Jaekyung ; Nishida, Naoshi ; Ang, Celina ; Marron, Thomas ; Wu, Linda ; Saeed, Anwaar ; Wietharn, Brooke ; Cammarota, Antonella ; Pressiani, Tiziana ; Pinter, Matthias ; Balcar, Lorenz ; Huang, Yi-Hsiang ; Mehan, Aman ; Phen, Samuel ; Vivaldi, Caterina ; Salani, Francesca ; Masi, Gianluca ; Bettinger, Dominik ; Vogel, Arndt ; Schoenlein, Martin ; von Felden, Johann ; Schulze, Kornelius ; Wege, Henning ; Samson, Adel ; Galle, Peter ; Kudo, Masatoshi ; Cortellini, Alessio ; Singal, Amit ; Rimassa, Lorenza ; Sharma, Rohini ; Chon, Hong Jae ; Pinato, David J.
Source
In Journal of Hepatology June 2023 78 Supplement 1:S575-S575
Subject
Language
ISSN
0168-8278